EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell Response

Marta Tiberi iD, Linda Petrone iD, Andrea Salmi, Valentina Vanini iD, Gilda Cuzzi, Alessandra D'Abramo iD, Patrizia De Marco iD, Alba Grifoni iD, Daniela Weiskopf iD, Alessandro Sette iD, Emanuele Nicastri iD, Delia Goletti iD

Pathogens · 2025

DOI: 10.3390/pathogens15010005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Marta Tiberi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Unit, National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, 00149 Rome, Italy. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Dengue Virus, Dengue, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Ministero della Salute, Italian Ministry of Health, Ricerca Corrente Linea 1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Being central players in the adaptive immunity, the study of T-cell responses is crucial in both natural infections and vaccine-induced immunity. In this study, we assessed the antigen-specific T-cell responses to dengue virus (DENV) to identify the most immunogenic antigen for evaluating dengue-specific T-cell responses.

Methods

Patients with dengue disease and subjects vaccinated with the QDENGA (TAK-003) vaccine (before and three months after vaccination) were enrolled. The T-cell-specific response was measured by ELISPOT and Activation Induced Markers (AIM) assay following PBMC stimulation either with DENV1-4 CD4 and CD8 MegaPools (MP) or serotype-specific DENV peptide pools at different concentrations.

Results

We found that both DENV1-4 CD4 MP (at 1 µg/mL) and CD8 MP (at 5 µg/mL), which encompass all four DENV serotypes, elicited specific T-cell responses in patients with dengue infection independent of the infecting serotype. In contrast, selected serotype-specific DENV peptide pools have a lower ability to induce a measurable T-cell response. Moreover, DENV1-4 CD4 and CD8 MPs, at the highest concentrations, are suitable candidates to evaluate the dengue-specific T-cell response in vaccinated subjects.

Conclusions

These findings support the use of the MP approach to investigate dengue-specific T-cell response to monitor the response during the infection and after vaccine administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesDengue VirusDengueCD4-Positive T-LymphocytesPeptidesHumansDengue VaccinesFemaleMaleAntigens, ViralAdultVaccinationMiddle Aged

Stichwörter der Autor:innen

CD4 and CD8 T cell responseQDENGA vaccineT cell responsecross-reactive memory responsedenguedengue diseasedengue vaccination

Substanzen

Dengue VaccinesAntigens, ViralPeptides

Autor:innen und Institutionen

  • Translational Research Unit, National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, 00149 Rome, Italy.
  • Professioni Sanitarie Tecniche, National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, 00149 Rome, Italy.
  • Clinical Disease Unit, National Institute for Infectious Diseases "L. Spallanzani"-IRCCS, 00149 Rome, Italy.
  • Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
  • Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA 92093, USA.

ORCID-Profile: Marta Tiberi, Linda Petrone, Valentina Vanini, Alessandra D'Abramo, Patrizia De Marco, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Emanuele Nicastri, Delia Goletti

Förderung

  • NIAID NIH HHS
  • Ministero della Salute
  • Italian Ministry of Health, Ricerca Corrente Linea 1
  • NIAID/NIH

Zitieren

APA

Tiberi, M., Petrone, L., Salmi, A., Vanini, V., Cuzzi, G., D'Abramo, A., De Marco, P., Grifoni, A., Weiskopf, D., Sette, A., Nicastri, E., & Goletti, D. (2025). Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell Response. Pathogens. https://doi.org/10.3390/pathogens15010005

Vancouver

Tiberi M, Petrone L, Salmi A, Vanini V, Cuzzi G, D'Abramo A, et al. Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell Response. Pathogens. 2025. doi:10.3390/pathogens15010005

BibTeX
@article{Tiberi2025,
  author = {Tiberi, Marta and Petrone, Linda and Salmi, Andrea and Vanini, Valentina and Cuzzi, Gilda and D'Abramo, Alessandra and De Marco, Patrizia and Grifoni, Alba and Weiskopf, Daniela and Sette, Alessandro and Nicastri, Emanuele and Goletti, Delia},
  title = {Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell Response},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens15010005}
}
Kostenlos starten →